Austin Health Care

Established in the year 1994, we, Austin Health Care are counted among the industry leading manufacturers and suppliers of a wide range of Medicines. Our organization is certified ISO 9001:2000 by American Quality Assessors, USA since 2001. Our range of pharmaceutical medicines includes black gold tablet, gastropain gel, crex gel, nimulex-p tab / susp, bro-austiclox cap, kid-98 susp, cally -3 plus tab, nosyfed forte susp, odyflex tab, nosyfed susp, tegxol expt, austifer tablet, hocta expt., nimulex-150 tablet, nosyfed tab, omip-20 cap, d-20 capsule and audi-250 / 500 tab.

Austin was introduced by Mr. Mahavir Dipchand Gadiya who is a technocrat. Mr. Gadiya is M.Pharm ( 3 rd in University ), DMM ( 1 st in Unievrsity ). After acquiring successful experience in Pharma selling for almost 12 years from Medical Representative to All India Sales Manager in Pharma Groups like Lupin, Cipla and Plethico. Mr. Gadiya has started his new venture by name - AUSTIN HEALTH CARE

Keeping pace with the growing market demand we have introduced various revolutionary and innovative medicines in the domestic market.

At AUSTIN, we have 3 types of marketing operations.

    Marketing of our products in few states with the help of our own Medical Representatives and marketing team.

    Concentration on Hospital Bulk Business.

    Appointment of marketing Agencies / Promotion-Cum-Distribution stocksit in unrepresented states and areas where products are sold on NET RATE BASIS.

We have received Rajiv Gandhi National Award in the year 2000 for our consistent performance in the field. Some of our prestigious clients are Major Municipal Corporation Hospitals, M.P.T. Goa , DDHS Goa, Cantonment Hospitals, Cardio Thoracic Centre, Air India & Indian Airlines, RBI & SBI, RCF, Mazgaon Dock, Cancer Hospitals and many more.

Under the able guidance of Mr. M. D. Gadiya, we have established a strong foothold in the domestic market. His dynamic mentorship motivates us to carve a niche in the world market by exporting our goods in near future.